PlainRecalls
FDA Drug Low Class III Terminated

Azelastine Hydrochloride Nasal Solution (Nasal Spray), 0.1% (137 mcg per spray), packaged in 30 mL bottles, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC 0054-0293-99

Reported: February 1, 2017 Initiated: December 14, 2016 #D-0448-2017

Product Description

Azelastine Hydrochloride Nasal Solution (Nasal Spray), 0.1% (137 mcg per spray), packaged in 30 mL bottles, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC 0054-0293-99

Reason for Recall

Defective Delivery System: out of specification result for droplet size distribution at the d90 measurement testing during the 6 month time point..

Details

Recalling Firm
Roxane Laboratories, Inc.
Units Affected
74,108 bottles
Distribution
Nationwide and Puerto Rico.
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Azelastine Hydrochloride Nasal Solution (Nasal Spray), 0.1% (137 mcg per spray), packaged in 30 mL bottles, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC 0054-0293-99. Recalled by Roxane Laboratories, Inc.. Units affected: 74,108 bottles.
Why was this product recalled?
Defective Delivery System: out of specification result for droplet size distribution at the d90 measurement testing during the 6 month time point..
Which agency issued this recall?
This recall was issued by the FDA Drug on February 1, 2017. Severity: Low. Recall number: D-0448-2017.